Rotow JK, Lee JK, Madison RW, Oxnard GR, et al. Real-world genomic profile of EGFR second-site mutations and other osimertinib resistance mechanisms, and clinical landscape of non-small cell lung cancer (NSCLC) post-osimertinib. J Thorac Oncol 2023 Oct 6:S1556-0864(23)02263.
PMID: 37806383